These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9016383)

  • 21. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.
    Akhtar N; Varma A; Pathak K
    Curr Clin Pharmacol; 2016; 11(3):168-190. PubMed ID: 27526697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
    Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.
    Chacko IA; Ghate VM; Dsouza L; Lewis SA
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111262. PubMed ID: 32736123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
    Gupta PN; Mishra V; Rawat A; Dubey P; Mahor S; Jain S; Chatterji DP; Vyas SP
    Int J Pharm; 2005 Apr; 293(1-2):73-82. PubMed ID: 15778046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proniosomes in transdermal drug delivery.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfersomes for transdermal drug delivery.
    Benson HA
    Expert Opin Drug Deliv; 2006 Nov; 3(6):727-37. PubMed ID: 17076595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
    Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
    Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride.
    Wang J; Wei Y; Fei YR; Fang L; Zheng HS; Mu CF; Li FZ; Zhang YS
    Int J Pharm; 2017 Nov; 533(1):266-274. PubMed ID: 28943208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
    Akhtar N
    Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation.
    Abd El-Alim SH; Kassem AA; Basha M; Salama A
    Int J Pharm; 2019 May; 563():293-303. PubMed ID: 30951860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcutaneous drug delivery by liposomes using fractional laser technology.
    Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
    Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal delivery from liposomal formulations - Evolution of the technology over the last three decades.
    Ashtikar M; Nagarsekar K; Fahr A
    J Control Release; 2016 Nov; 242():126-140. PubMed ID: 27620074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
    Cevc G; Vierl U
    J Control Release; 2010 Feb; 141(3):277-99. PubMed ID: 19850095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
    Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
    Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.